PP
AGN

Paloma Partners’s Allergan plc AGN Stock Holding History

Paloma Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-59,966
Closed -$10.6M – 2330
2020
Q1 		$10.6M Buy
59,966
+27,905
+87% +$5.25M 0.6% 21
2019
Q4 		$6.13M Buy
32,061
+30,022
+1,472% +$5.42M 0.09% 186
2019
Q3 		$343K Sell
2,039
-48,734
-96% -$7.94M 0.01% 1439
2019
Q2 		$8.5M Buy
50,773
+26,902
+113% +$3.73M 0.14% 120
2019
Q1 		$3.5M Buy
23,871
+17,332
+265% +$2.51M 0.08% 267
2018
Q4 		$874K Buy
+6,539
New +$1.07M 0.03% 502
2018
Q3 		– Sell
-2,349
Closed -$432K – 42
2018
Q2 		$391K Sell
2,349
-7,565
-76% -$1.21M 0.01% 1139
2018
Q1 		$1.67M Buy
+9,914
New +$1.66M 0.03% 677
2017
Q4 		– Sell
-1,667
Closed -$342K – 2452
2017
Q3 		$342K Sell
1,667
-17,061
-91% -$3.97M ﹤0.01% 1744
2017
Q2 		$4.55M Buy
18,728
+9,437
+102% +$2.22M 0.05% 355
2017
Q1 		$2.22M Sell
9,291
-47,263
-84% -$11M 0.03% 721
2016
Q4 		$11.9M Buy
56,554
+48,149
+573% +$9.97M 0.12% 100
2016
Q3 		$1.94M Sell
8,405
-8,055
-49% -$1.97M 0.02% 565
2016
Q2 		$3.8M Sell
16,460
-64,288
-80% -$14.8M 0.04% 368
2016
Q1 		$21.6M Sell
80,748
-15,596
-16% -$4.46M 0.36% 34
2015
Q4 		$30.1M Buy
+96,344
New +$28.7M 0.8% 10
2015
Q3 		– Sell
-5,131
Closed -$1.58M – 2069
2015
Q2 		$1.56M Sell
5,131
-1,937
-27% -$578K 0.03% 551
2015
Q1 		$2.1M Sell
7,068
-2,398
-25% -$684K 0.06% 290
2014
Q4 		$2.44M Buy
9,466
+2,366
+33% +$591K 0.1% 204
2014
Q3 		$1.71M Buy
+7,100
New +$1.59M 0.08% 251
2013
Q4 		– Sell
-2,100
Closed -$302K – 1253
2013
Q3 		$302K Buy
+2,100
New +$280K 0.01% 633

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Paloma Partners's AGN Position: Q2 2020 in Review

Paloma Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 59,966 shares — an estimated $10.6M sold.

Paloma Partners first reported a position in AGN in Q3 2013 and held it in 21 quarters. The position peaked at $30.1M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Paloma Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Paloma Partners sold 59,966 Allergan plc shares in Q2 2020, an estimated $10.6M.
  • Paloma Partners first reported a position in Allergan plc in Q3 2013 and held it in 21 quarters.
  • Paloma Partners's Allergan plc position peaked at $30.1M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Paloma Partners's 13F filing for Q2 2020, filed 14 Aug 2020.